Stay updated on Radiation Doses for Immunotherapy Progression Clinical Trial

Sign up to get notified when there's something new on the Radiation Doses for Immunotherapy Progression Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Radiation Doses for Immunotherapy Progression Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:37:04.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the number of lesions that can be treated with Stereotactic Body Radiation Therapy (SBRT) in the study. This change may impact the eligibility criteria for participants with limited progression on immune checkpoint blockade.
    Difference
    0.1%
    Check dated 2024-06-06T14:46:21.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to provide detailed eligibility criteria for study participants, including requirements for informed consent, compliance with study obligations, and specific health conditions. Previously, this section indicated that no information was provided.
    Difference
    38%
    Check dated 2024-05-22T21:29:48.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2024-04-30T22:39:35.000Z thumbnail image

Stay in the know with updates to Radiation Doses for Immunotherapy Progression Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Radiation Doses for Immunotherapy Progression Clinical Trial page.